Scott Rocklage is the co-founding partner at 5am Ventures. He since joined the company back in 2003 and quickly became the managing partner in 2004. This company is the leading venture firm in developing next generation life-science. They support other companies in building ground-breaking medicine and researching health sciences. They range from preventing numerous illnesses, to even diagnoses. 5am Venture consists of a team full of investors that are all experts in:
• strong scientific and medical research
• legal operations
Scott Rocklage has had over 20 years of healthcare management and leadership experience. He is also responsible for three U.S New Drug Applications getting approved by the FDA and six other drugs being entered into clinical trials. In his early life, Rocklage went to study at the University of California and graduated with a Bachelor of Science degree in Chemistry. After that, he decided to pursue his Ph.D in Chemistry and obtained it from the Massachusetts Institute of Technology. Learn more: https://www.dialdish.com/scott-rocklage-seeks-to-conquer-cancer-by-targeting-mutant-rna-molecules/
Dr. Rocklage is now partnering with Expansion Therapeutics in finding a cure for different diseases concerning RNA-triggered illnesses. Now, these different diseases can be treated with medications and Expansion Therapeutics won’t rest until they’ve figured one out. Dr. Scott Rocklage is also by their side each step of the way trying to figure out other options for patients.
Myotonic Dystrophy Type I, or in other words, DM1 has been the leading cause of muscular dystrophy in adults. This mainly happens when RNA levels reach a toxic proportion in the human body. It can be very life-therenting for anyone as many of the body’s systems begin to shut down including the:
• Respiratory system
• Central nervous system
• Heart and Muscles
• Gastrointestinal system
• Hormonal system
Since many of these RNA illnesses are hereditary, Expansion Therapeutics knew something had to be done.
As a result of this, the company decided to add over $55 million dollars to cover expenses in order to find a cure! With this new budget, Rocklage and his team is there to help with all the leading and financing!